Section 21 (South Africa) in Jordan
How the section 21 (south africa) pathway operates in Jordan.
About Section 21 (South Africa)
South Africa's SAHPRA pathway for access to unregistered medicines.
How Section 21 (South Africa) works in Jordan
Jordan's JFDA operates a compassionate-use framework for unregistered drugs; requires physician and JFDA approval.
Patients in Jordan seeking access under Section 21 (South Africa) typically follow this flow: a licensed physician in Jordan issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Jordan
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.